Amantadine in Parkinson's disease.
D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D000547:Amantadine